Decision-tree model for health economic comparison of two long-acting somatostatin receptor ligand devices in France, Germany, and the UK

por Marty, Rémi, Roze, Stéphane, Kurth, Hannah
Publicado 2012

Cost-effectiveness of alectinib compared to crizotinib for the treatment of first-line ALK+ advanced non-small-cell lung cancer in France

por Sivignon, Marine, Monnier, Rémi, Tehard, Bertrand, Roze, Stéphane
Publicado 2020

Water intake and recurrent urinary tract infections prevention: economic impact analysis in seven countries

por Zemdegs, Juliane, Iroz, Alison, Vecchio, Mariacristina, Roze, Stephane, Lotan, Yair
Publicado 2023

Evaluation of the cost per patient per injection of botulinum toxin A in upper limb spasticity: comparison of two preparations in 19 countries

por Roze, Stéphane, Kurth, Hannah, Hunt, Barnaby, Valentine, William, Marty, Rémi
Publicado 2012

A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France

por Bresse, Xavier, Adam, Marjorie, Largeron, Nathalie, Roze, Stephane, Marty, Remi
Publicado 2013

Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada

por Roze, Stephane, Isitt, John J, Smith-Palmer, Jayne, Lynch, Peter
Publicado 2021

Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe

por Marty, Rémi, Roze, Stéphane, Bresse, Xavier, Largeron, Nathalie, Smith-Palmer, Jayne
Publicado 2013

Cost-effectiveness of bevacizumab plus paclitaxel versus paclitaxel for the first-line treatment of HER2-negative metastatic breast cancer in specialist oncology centers in France

por Petitjean, Audrey, Smith-Palmer, Jayne, Valentine, William, Tehard, Bertrand, Roze, Stephané
Publicado 2019

Budget Impact Analysis of Impella CP(®) Utilization in the Management of Cardiogenic Shock in France: A Health Economic Analysis

por Delmas, Clément, Pernot, Mathieu, Le Guyader, Alexandre, Joret, Romain, Roze, Stéphane, Lebreton, Guillaume
Publicado 2022

Budget Impact Associated with the Introduction of the Impella 5.0(®) Mechanical Circulatory Support Device for Cardiogenic Shock in France

por Le Guyader, Alexandre, Pernot, Mathieu, Delmas, Clément, Roze, Stéphane, Fau, Isabelle, Flecher, Erwan, Lebreton, Guillaume
Publicado 2021

Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Swed...

por Jendle, Johan, Smith-Palmer, Jayne, Delbaere, Alexis, de Portu, Simona, Papo, Natalie, Valentine, William, Roze, Stéphane
Publicado 2017

Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in France

por Pignata, Maud, Chouaid, Christos, Le Lay, Katell, Luciani, Laura, McConnachie, Ceilidh, Gordon, James, Roze, Stéphane
Publicado 2017

The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatide QW for the Treatment of Patients with Type 2 Diabetes Mellitus in France

por Basson, Mickael, Ntais, Dionysios, Ayyub, Ruba, Wright, Donna, Lowin, Julia, Chartier, Florence, Roze, Stéphane, Norrbacka, Kirsi
Publicado 2017

Cost-Effectiveness of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Patients with Poorly Controlled Type 2 Diabetes in Finland

por Roze, Stephané, Smith-Palmer, Jayne, Delbaere, Alexis, Bjornstrom, Karita, de Portu, Simona, Valentine, William, Honkasalo, Mikko
Publicado 2019

Modelling Survival of Patients Treated with Adjuvant Nivolumab Who Have Melanoma with Lymph Node Involvement or Metastatic Disease After Complete Resection

por Batteson, Rachael, Hart, Rose, Hemstock, Matthew, Gooden, Kyna, Kotapati, Srividya, Roze, Stephane, Lee, Dawn, Amadi, Adenike
Publicado 2019

Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands

por Roze, Stephané, Smith-Palmer, Jayne, de Portu, Simona, Delbaere, Alexis, de Brouwer, Bonnie, de Valk, Harold W
Publicado 2019

Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France

por Roze, Stéphane, Isitt, John J., Smith-Palmer, Jayne, Lynch, Peter, Klinkenbijl, Brigitte, Zammit, Gerald, Benhamou, Pierre-Yves
Publicado 2020

Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System Versus Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Insulin Therapy in the UK

por Isitt, John J., Roze, Stéphane, Sharland, Helen, Cogswell, Greg, Alshannaq, Hamza, Norman, Gregory J., Lynch, Peter M.
Publicado 2022

Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada

por Alshannaq, Hamza, Isitt, John J, Pollock, Richard F, Norman, Gregory J, Cogswell, Greg, Lynch, Peter M, Roze, Stéphane
Publicado 2023

Cost–Utility Analysis of Nivolumab in Adjuvant Treatment of Melanoma in France

por Bregman, Bruno, Teitsson, Siguroli, Orsini, Isabella, Cotté, François-Emery, Amadi, Adenike, Moshyk, Andriy, Roze, Stéphane, Gaudin, Anne-Françoise
Publicado 2020